Expression of mdm2 and p53 in epithelial neoplasms of the colorectum

被引:15
|
作者
Hao, XP
Günther, T
Roessner, A
Price, AB
Talbot, IC
机构
[1] Northwick Pk & St Marks NHS Trust, Acad Dept Pathol, Harrow HA1 3UJ, Middx, England
[2] Otto Von Guericke Univ, Dept Pathol, Magdeburg, Germany
来源
关键词
mdm2; p53; colorectal carcinoma;
D O I
10.1136/mp.51.1.26
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To evaluate the respective roles of mdm2 (murine double minute 2) and p53 in the development of colorectal carcinoma. Methods-Formalin fixed, paraffin wax embedded tissues from 72 sporadic adenomas and 55 carcinomas were investigated by means of immunohistochemistry for mdm2 and p53. Results-mdm2 was expressed weakly in 17 of 72 (23.6%) adenomas and in 14 of 55 (25.4%) carcinomas. p53 was expressed in 19 of 72 (26.4%) adenomas and in 23 of 55 (41.8%) carcinomas. Four adenomas and five carcinomas showed positive staining for both proteins. Overexpression of p53 in adenomas was associated with moderate and severe dysplasia but not with tumour size. No associations were found between the expression of mdm2 and either the degree of dysplasia or tumour size. In carcinomas, neither the expression of p53 nor mdm2 correlated with Dukes's stage, metastasis, or differentiation. No associations were found between the expression of p53 and mdma in either adenomas or carcinomas. Conclusions-Although mdm2 has been reported to be an oncogene, it does not appear to play a major role in the development of colorectal carcinoma.
引用
收藏
页码:26 / 29
页数:4
相关论文
共 50 条
  • [1] Expression of mdm2 and p53 in epithelial neoplasms of the colorectum
    Hao, XP
    Gunther, T
    Roessner, A
    Price, AB
    Talbot, IC
    [J]. GUT, 1997, 41 : A257 - A257
  • [2] MDM2 and p53 expression in ampullary adenocarcinomas
    Perysinakis, I.
    Leontara, V.
    Minaidou, E.
    Karambogias, C.
    Choreftaki, T.
    Zografos, G.
    Kouraklis, G.
    [J]. VIRCHOWS ARCHIV, 2015, 467 : S126 - S126
  • [3] The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor
    Eskandari, Mohammad
    Shi, Yang
    Liu, John
    Albanese, Joseph
    Goel, Swati
    Verma, Amit
    Wang, Yanhua
    [J]. LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 167 - 175
  • [4] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
  • [5] MDM2与p53
    金晶
    刘耕陶
    [J]. 癌症, 2001, (06) : 663 - 666
  • [6] MDM2 and BCL-2: to p53 or not to p53?
    Wang, Eunice S.
    [J]. BLOOD, 2023, 141 (11) : 1237 - 1238
  • [7] Binding of an inhibitor of the p53/MDM2 interaction to MDM2
    Duncan, SJ
    Cooper, MA
    Williams, DH
    [J]. CHEMICAL COMMUNICATIONS, 2003, (03) : 316 - 317
  • [8] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk
    Roberto Salvi
    Manuela Argentini
    Christine Dureuil
    Isabelle Delumeau
    Joseph Abecassis
    Laurent Debussche
    Bohdan Wasylyk
    [J]. Oncogene, 1999, 18 : 1921 - 1934
  • [9] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Wasylyk, C
    Salvi, R
    Argentini, M
    Dureuil, C
    Delumeau, I
    Abecassis, J
    Debussche, L
    Wasylyk, B
    [J]. ONCOGENE, 1999, 18 (11) : 1921 - 1934
  • [10] p53 and MDM2 expression in odontogenic cysts and tumours
    Carvalhais, JN
    de Aguiar, MCF
    de Araújo, VC
    de Araújo, NS
    Gomez, RS
    [J]. ORAL DISEASES, 1999, 5 (03) : 218 - 222